Jazz Pharmaceuticals PLC: Citigroup initiates coverage with buy rating; target price $325
JAZZ•Citigroup initiated coverage of Jazz Pharmaceuticals with a buy rating and a $325 target price.
JAZZ•JAZZ•JAZZ•Citigroup initiated coverage of Jazz Pharmaceuticals with a buy rating and a $325 target price.
